These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 35048593)

  • 21. Exploring the Emerging Role of the Gut Microbiota and Tumor Microenvironment in Cancer Immunotherapy.
    Qiu Q; Lin Y; Ma Y; Li X; Liang J; Chen Z; Liu K; Huang Y; Luo H; Huang R; Luo L
    Front Immunol; 2020; 11():612202. PubMed ID: 33488618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Remodeling tumor microenvironment with nanomedicines.
    Martin JD; Miyazaki T; Cabral H
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Nov; 13(6):e1730. PubMed ID: 34124849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of cancer-immunity cycle and tumor microenvironment by nanobiomaterials to enhance tumor immunotherapy.
    Yang J; Zhang C
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Jul; 12(4):e1612. PubMed ID: 32114718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor Microenvironment Immunosuppression: A Roadblock to CAR T-Cell Advancement in Solid Tumors.
    Johnson A; Townsend M; O'Neill K
    Cells; 2022 Nov; 11(22):. PubMed ID: 36429054
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Roles of CD38 and CD157 in the Solid Tumor Microenvironment and Cancer Immunotherapy.
    Wo YJ; Gan ASP; Lim X; Tay ISY; Lim S; Lim JCT; Yeong JPS
    Cells; 2019 Dec; 9(1):. PubMed ID: 31861847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploring the landscape of drug resistance in gastrointestinal cancer immunotherapy: A review.
    Yao N; Li W; Duan N; Xu G; Yu G; Qu J
    Medicine (Baltimore); 2024 Jan; 103(2):e36957. PubMed ID: 38215151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural killer cell dysfunction in cancer and new strategies to utilize NK cell potential for cancer immunotherapy.
    Zhang W; Zhao Z; Li F
    Mol Immunol; 2022 Apr; 144():58-70. PubMed ID: 35203022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypoxia-modulatory nanomaterials to relieve tumor hypoxic microenvironment and enhance immunotherapy: Where do we stand?
    Yuan CS; Deng ZW; Qin D; Mu YZ; Chen XG; Liu Y
    Acta Biomater; 2021 Apr; 125():1-28. PubMed ID: 33639310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Fc-VEGF chimeric fusion enhances PD-L1 immunotherapy via inducing immune reprogramming and infiltration in the immunosuppressive tumor microenvironment.
    Kuo CL; Chou HY; Lien HW; Yeh CA; Wang JR; Chen CH; Fan CC; Hsu CP; Kao TY; Ko TM; Lee AY
    Cancer Immunol Immunother; 2023 Feb; 72(2):351-369. PubMed ID: 35895109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multifunctional nanocomposites modulating the tumor microenvironment for enhanced cancer immunotherapy.
    Sharma P; Otto M
    Bioact Mater; 2024 Jan; 31():440-462. PubMed ID: 37701452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-angiogenesis: Opening a new window for immunotherapy.
    Guo F; Cui J
    Life Sci; 2020 Oct; 258():118163. PubMed ID: 32738363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of tumor microenvironment in cancer progression and therapeutic strategy.
    Wang Q; Shao X; Zhang Y; Zhu M; Wang FXC; Mu J; Li J; Yao H; Chen K
    Cancer Med; 2023 May; 12(10):11149-11165. PubMed ID: 36807772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting hypoxia and hypoxia-inducible factor-1 in the tumor microenvironment for optimal cancer immunotherapy.
    Kheshtchin N; Hadjati J
    J Cell Physiol; 2022 Feb; 237(2):1285-1298. PubMed ID: 34796969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vista of the Future: Novel Immunotherapy Based on the Human V-Set Immunoregulatory Receptor for Digestive System Tumors.
    Chmiel P; Gęca K; Michalski A; Kłosińska M; Kaczyńska A; Polkowski WP; Pelc Z; Skórzewska M
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nanoengineered strategies to optimize dendritic cells for gastrointestinal tumor immunotherapy: from biology to translational medicine.
    Bhargava A; Bunkar N; Khare NK; Mishra D; Mishra PK
    Nanomedicine (Lond); 2014 Jul; 9(14):2187-202. PubMed ID: 25405796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conserved pan-cancer microenvironment subtypes predict response to immunotherapy.
    Bagaev A; Kotlov N; Nomie K; Svekolkin V; Gafurov A; Isaeva O; Osokin N; Kozlov I; Frenkel F; Gancharova O; Almog N; Tsiper M; Ataullakhanov R; Fowler N
    Cancer Cell; 2021 Jun; 39(6):845-865.e7. PubMed ID: 34019806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting tumor immunosuppressive microenvironment for pancreatic cancer immunotherapy: Current research and future perspective.
    Li Y; Xiang S; Pan W; Wang J; Zhan H; Liu S
    Front Oncol; 2023; 13():1166860. PubMed ID: 37064113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent Advances in CAR-Based Solid Tumor Immunotherapy.
    Shin MH; Oh E; Kim Y; Nam DH; Jeon SY; Yu JH; Minn D
    Cells; 2023 Jun; 12(12):. PubMed ID: 37371075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reprogramming the immunosuppressive tumor microenvironment: exploiting angiogenesis and thrombosis to enhance immunotherapy.
    Shafqat A; Omer MH; Ahmed EN; Mushtaq A; Ijaz E; Ahmed Z; Alkattan K; Yaqinuddin A
    Front Immunol; 2023; 14():1200941. PubMed ID: 37520562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetically engineered macrophages persist in solid tumors and locally deliver therapeutic proteins to activate immune responses.
    Brempelis KJ; Cowan CM; Kreuser SA; Labadie KP; Prieskorn BM; Lieberman NAP; Ene CI; Moyes KW; Chinn H; DeGolier KR; Matsumoto LR; Daniel SK; Yokoyama JK; Davis AD; Hoglund VJ; Smythe KS; Balcaitis SD; Jensen MC; Ellenbogen RG; Campbell JS; Pierce RH; Holland EC; Pillarisetty VG; Crane CA
    J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33115946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.